Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 58Breast Neoplasms 54Lymphoma 52Multiple Myeloma 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Leukemia 48Lymphoma, Non-Hodgkin 46Melanoma 43Lymphoma, Large B-Cell, Diffuse 41Leukemia, Lymphocytic, Chronic, B-Cell 40Myelodysplastic Syndromes 39Lymphoma, Follicular 29Burkitt Lymphoma 25Hodgkin Disease 24Neoplasm Metastasis 22Recurrence 21Neoplasms 21Lymphoma, Mantle-Cell 20Lymphoma, B-Cell, Marginal Zone 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Ovarian Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Primary Myelofibrosis 14Neoplasms, Plasma Cell 14Myeloproliferative Disorders 14Lymphoma, B-Cell 14Hematologic Neoplasms 14Leukemia, Myelomonocytic, Chronic 13Carcinoma, Renal Cell 13Triple Negative Breast Neoplasms 12

Interventions

Surgical Procedures, Operative 2Magnetic Resonance Spectroscopy 2pembrolizumab 1pasireotide 1gallium Ga 68 dotatate 1gadobutrol 1gadobenic acid 1fluoromisonidazole 1avelumab 1antineoplaston AS 2-1 1antineoplaston A10 1Yoga 1Topotecan 1Temozolomide 1Radiotherapy 1Radiosurgery 1Proton Therapy 1Panobinostat 1Methylphenidate 1Magnetic Resonance Imaging 1Irinotecan 1Ifosfamide 1HDAC-42 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Everolimus 1Cyclophosphamide 1Congresses as Topic 1Bevacizumab 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Meningioma × Cyclophosphamide × Clear all
NCT04239092 2025-07-17

9-ING-41 in Pediatric Patients With Refractory Malignancies.

Actuate Therapeutics Inc.

Phase 1 Terminated
40 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Meningioma, Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡